Navigation Links
Video: Higher Initial Dose of Gleevec Achieved Better Early Responses than Standard Dose for Patients with Chronic Myeloid Leukemia
Date:6/13/2008

- Efficacy and safety profile in large randomized Phase III study consistent with landmark IRIS trial, which established Gleevec as standard

of care - Study did not meet primary endpoint at 1 year, yet shows faster time to

molecular responses with 800 vs. 400 mg dose - Findings reinforce that monitoring blood levels of Gleevec may help

optimize treatment benefit for individual patients - Novartis committed to improving first-line treatment through additional study follow-up and completing enrollment to Tasigna vs. Gleevec trial

EAST HANOVER, N.J., June 13 /PRNewswire/ -- New data from a large, international clinical trial find that patients with newly diagnosed chronic myeloid leukemia who received Gleevec(R) (imatinib meslyate) tablets at 800 mg/day as their initial treatment achieved clinical milestones significantly faster than those receiving the standard 400 mg/day dose.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/novartis/33488/

The Tyrosine Kinase Inhibitor Optimization and Selectivity Study (TOPS) is the first Phase III, randomized, controlled clinical trial designed to evaluate the potential benefits of an 800 mg starting dose across all risk categories of newly diagnosed, previously untreated patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).

Numerically, more patients achieved a major molecular response (MMR) with the 800 mg dose than the 400 mg dose (46.4% vs. 40.1%); however, the difference between the two arms -- the primary endpoint of the study -- was not statistically significant. This trend of improved MMR rate at 12 months in the 800 mg vs. 400 mg arms was most pronounced in the subset of patients with the highest risk for disease progression (41.1% vs. 26.2%). Further, patients in the 800 mg a
'/>"/>

SOURCE Novartis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Video: Data From 185,000 ICU Admissions Show Significant Reductions in Mortality:
2. Video: New Survey Finds Technology Plays a Critical Role in Lives of People with Multiple Sclerosis, Yet Many Are Not Using it to Overcome Disease-Related Challenges
3. Video: Trinity Mother Frances Neurosurgeon Using New Disc System for Patients With Degenerative Diseases of the Neck
4. Major Medical Journal Reports Higher Success, Fewer Complications and Lower Cost Treating DVT With Trellis(R) Isolated Thrombolysis Compared With Catheter-Directed Thrombolysis
5. ChemAxon Launches Marvin and JChem Version 5: Better User Experience, Better Integration, More Flexibility and Higher Performance
6. EMEA Accepts for Review Vidaza(R) Marketing Authorization Application for Higher-Risk Myelodysplastic Syndromes
7. Notice of Initial Distribution of Net Settlement Funds
8. Awareness of Genzymes Renvela(R) (Sevelamer Carbonate) is High, Although Uptake of this New Phosphate Binding Agent has Been Slower than Nephrologists and Renal Dietitians Initially Expected
9. QLT reports initial proof of concept data for punctal plug delivery technology
10. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
11. Ferring Initial Purchase Order and Guaranteed Letter of Credit Launches Five Year Contract
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... Thornton Cleveleys (UK) (PRWEB) April 21, 2015 ... PEEK* technology and its clinical applications will ... Meeting. Participants include engineers, scientists, regulators and ... worldwide. The meeting is sponsored by Invibio ... PEEK polymer-based biomaterials, a specialist in manufacturing ...
(Date:4/20/2015)... , April 20, 2015 Stent retriever ... from vessels in the brain reduced disability after ... Tudor Jovin, MD, President of the Society of ... "This is a giant step forward that will ... of stroke patients," said Jovin, who is associate ...
(Date:4/20/2015)... 2015  Ardelyx, Inc. (NASDAQ: ARDX ), ... and metabolic diseases, today announced that Annalisa ... Board of Directors. Dr. Jenkins brings a wealth ... built and led teams advancing programs from scientific ... healthcare systems globally. "Annalisa brings ...
(Date:4/20/2015)... , April 20, 2015 ... Targeting Supramolecular Therapeutic Using the VOLVOX Platform - To ... -  Supramolecular Assembly of Antibody-drug Conjugates ... Payload - Presented on Sunday, Apr 19, 1:00 PM ... in supramolecular therapeutic program, today announced that the company,s ...
Breaking Biology Technology:2nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 22nd International PEEK Meeting: Invibio Biomaterial Solutions spearheads medical research for implantable PEEK polymer devices 3SVIN President Tudor Jovin, MD, Co-Leads Groundbreaking Stroke Study In The New England Journal Of Medicine 2SVIN President Tudor Jovin, MD, Co-Leads Groundbreaking Stroke Study In The New England Journal Of Medicine 3Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 2Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 3Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors 4Invictus Oncology Announces Two Posters to be Presented Describing its Platform Technology on Supramolecular Therapeutics at the American Association for Cancer Research Annual Meeting, 2015 2
... 33% more data than the previous product generation. ... of the 1.5 GB Cornice Storage Element (SE), ... Element. These storage devices are used in consumer ... amounts of reliable, inexpensive storage in a small space. ...
... of Silicon Valley has joined the doom of Y2K in ... to revisit the importance of technology to Northeast Wisconsin. After ... the so-called new economy, one fact remains: More money must ... , ,In this post-technology age, the only thing about technology ...
... Brookfield, Wis. - Fiserv Health, an operating group of ... Avidyn Health, a care management company targeting the self-funded ... provides independent health plan management, claims processing and administration ... With the addition of Avidyn Health, Fiserv Health now ...
Cached Biology Technology:With Larger Storage Capacity Comes Smaller Devices 2Look at the New Economy, Just Like the Old Economy 2Fiserv Launches Avidyn Health to Target Healthcare Costs 2
(Date:4/14/2015)... OXFORD, Conn. , April 14, 2015 ... "Company"), a biometric authentication company focused on the growing ... has been nominated for the 2015 New York Design ... The Design100, New York City Design Awards are ... are based on over 2,500 ratings from the marketplace, ...
(Date:4/8/2015)... 8, 2015  Infinisource, a leading provider of SaaS-based ... Morpho, a leading supplier of biometric identification and ... market,s most advanced biometrically-enabled time clock, the companies ... clock is setting a bold, new standard for ... the small and mid-size employer. When connected to ...
(Date:4/2/2015)... GOTHENBURG, Sweden , April 2, 2015 ... for its touch fingerprint sensor FPC1025 from the distributor ... Deliveries will commence during Q2 2015 although the major ... 2015. The sensors will be used by smartphone manufacturers ... of 110 MSEK is included in the communicated revenue ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 2iSolved Time Clock Offers Unmatched Accuracy due to Morpho Biometrics 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2
... of Anthropology Jeffrey H. Schwartz and University of Salerno ... the New Anatomist journal, shows that the emerging understanding ... of evolution, originally explained in his seminal work, Sudden ... Wiley & Sons, 2000). , In that book, Schwartz ...
... simplest bacteria need almost twice as many genes to survive ... Nature (30 March 2006). , Bacteria are some of the ... trying to identify the smallest collection of genes ?or minimal ... scientists have done this by removing, or 'knocking out', a ...
... the 3-billion-base human genome play a vital role in ... the Wellcome Trust Sanger Institute and the Cambridge University's ... report in PLoS Genetics their detailed maps of differences ... unchanged in recent human history. , The Major ...
Cached Biology News:Pitt professor's theory of evolution gets boost from cell research 2Pitt professor's theory of evolution gets boost from cell research 3Minimal genome should be twice the size, study shows 2Minimal genome should be twice the size, study shows 3Researchers map of genetic variations implicated in disease 2Researchers map of genetic variations implicated in disease 3
... are rigid macroporous hydrophilic media. The rigid ... moderate pressures, while the macroporous beads enhance ... matrix reduces nonspecific binding. Macro-Prep High Q ... with very high flow rates and resolution. ...
... --- a cocktail of 3 siRNAs specifically ... our most popular product. The siTrio reagent ... of your target gene when used under ... and confirmation of optimal transfection with one ...
... collection of phage display libraries, human ... and mouse tissues. All cDNA libraries ... size of cDNA inserts has been ... 1000bp by gel electrophoresis of DNA ...
... The IDS 25-Hydroxy Vitamin D kit ... quantitative determination of 25-hydroxyvitamin D (25-OH ... human serum or plasma. Our patented ... of solvent precipitation and centrifugation and ...
Biology Products: